Madrigal Pharmaceuticals

IPO

Home - Madrigal

Employees
51–200
Business Model
B2B
Last Round
Venture RoundJan 2016
Rounds
1
Type
Public

About

Clinical-stage biopharmaceutical company focused on developing therapies for metabolic diseases, including NASH/MASH liver disease.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

IPOJan 2021

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Create Free Account

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies